Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04659213 · ClinicalTrials.gov registry record · NA
Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation - EASY AF STUDY
A NA study of Atrial Fibrillation, sponsored by S4 Medical.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 1
- Study location
NCT04659213 is a NA study of Atrial Fibrillation that has completed, run by S4 Medical. The registered enrollment target is 129 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04659213, a NA study of Atrial Fibrillation, has completed, sponsored by S4 Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess if deviating the esophagus will reduce/eliminate ablation injury to the esophagus.
Conditions Studied
Interventions
- DEVICE esolution catheter
Study Locations (1)
Ohio
- OSU - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04659213
The ClinicalTrials.gov registry entry for NCT04659213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (96% lower). The listed sponsor is S4 Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which esolution catheter is the first listed.
NCT04659213 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04659213 about?
NCT04659213 is a clinical study titled "Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation - EASY AF STUDY". To assess if deviating the esophagus will reduce/eliminate ablation injury to the esophagus.
What is the current status of trial NCT04659213?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2021-09-01. Estimated completion is 2022-07-31.
What conditions does trial NCT04659213 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT04659213?
The interventions under investigation include: esolution catheter (DEVICE).
Who is sponsoring clinical trial NCT04659213?
This trial is sponsored by S4 Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04659213 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.